These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3466836)

  • 1. Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance.
    Pinzani M; Daskalopoulos G; Laffi G; Gentilini P; Zipser RD
    Gastroenterology; 1987 Feb; 92(2):294-8. PubMed ID: 3466836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
    Rector WG
    Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulindac and indomethacin suppress the diuretic action of furosemide in patients with cirrhosis and ascites: evidence that sulindac affects renal prostaglandins.
    Daskalopoulos G; Kronborg I; Katkov W; Gonzalez M; Laffi G; Zipser RD
    Am J Kidney Dis; 1985 Oct; 6(4):217-21. PubMed ID: 3901735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of prostaglandin E like material and kallikrein: effects of furosemide.
    Halushka PV; Margolius HS; Allen H; Conradi EC
    Prostaglandins; 1979 Sep; 18(3):359-68. PubMed ID: 260996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Diuretic-resistant' ascites. Observations on pathogenesis.
    Rector WG
    Arch Intern Med; 1986 Aug; 146(8):1597-600. PubMed ID: 3729643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of furosemide-induced natriuresis by direct stimulation of renal prostaglandin E2.
    Katayama S; Attallah AA; Stahl RA; Bloch DL; Lee JB
    Am J Physiol; 1984 Oct; 247(4 Pt 2):F555-61. PubMed ID: 6594069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate effects of furosemide on renal hemodynamics in chronic liver disease with ascites.
    Daskalopoulos G; Laffi G; Morgan T; Pinzani M; Harley H; Reynolds T; Zipser RD
    Gastroenterology; 1987 Jun; 92(6):1859-63. PubMed ID: 3569760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary evaluation of furosemide-probenecid interaction in humans.
    Smith DE; Gee WL; Brater DC; Lin ET; Benet LZ
    J Pharm Sci; 1980 May; 69(5):571-5. PubMed ID: 7381747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronopharmacological study of furosemide in rats.
    Fujimura A; Ebihara A
    Life Sci; 1986 Mar; 38(13):1215-20. PubMed ID: 3457231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrarenal thromboxane A2 generation reduces the furosemide-induced sodium and water diuresis in cirrhosis with ascites.
    Pinzani M; Laffi G; Meacci E; La Villa G; Cominelli F; Gentilini P
    Gastroenterology; 1988 Oct; 95(4):1081-7. PubMed ID: 3165896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of captopril on renal function in patients with cirrhosis and ascites.
    Daskalopoulos G; Pinzani M; Murray N; Hirschberg R; Zipser RD
    J Hepatol; 1987 Jun; 4(3):330-6. PubMed ID: 3298415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frusemide, ACE inhibition, renal dopamine and prostaglandins: acute interactions in normal man.
    MacDonald TM; Craig K; Watson ML
    Br J Clin Pharmacol; 1989 Dec; 28(6):683-94. PubMed ID: 2532921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of indomethacin on furosemide-stimulated urinary PGE2 excretion in man.
    Brater DC; Beck JM; Adams BV; Campbell WB
    Eur J Pharmacol; 1980 Jul; 65(2-3):213-9. PubMed ID: 7398787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrelationships between the renal kallikrein-kinin and prostaglandin systems in furosemide-induced diuresis.
    Ayano Y; Yamasaki K; Soejima H; Ikegami K
    Urol Int; 1984; 39(1):52-7. PubMed ID: 6587655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man.
    Homeida M; Roberts C; Branch RA
    Clin Pharmacol Ther; 1977 Oct; 22(4):402-9. PubMed ID: 902453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous furosemide.
    Li T; Lee MG; Chiou WL
    J Pharmacokinet Biopharm; 1986 Oct; 14(5):495-509. PubMed ID: 3806372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tienoxolol, a new diuretic beta-blocking agent, on urinary prostaglandin excretion in the rat.
    Caussade F; Cloarec A
    Br J Pharmacol; 1993 May; 109(1):278-84. PubMed ID: 8098641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites.
    Planas R; Arroyo V; Rimola A; Pérez-Ayuso RM; Rodés J
    Gastroenterology; 1983 Feb; 84(2):247-52. PubMed ID: 6401254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites.
    Spahr L; Villeneuve JP; Tran HK; Pomier-Layrargues G
    Hepatology; 2001 Jan; 33(1):28-31. PubMed ID: 11124817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.